Ark Restaurants, through its subsidiaries, owns and/or operates restaurants, bars, fast food concepts and catering operations. The company operates restaurant in New York City, Washington, D.C., Las Vegas, NV, Atlantic City, NJ, Florida and the Gulf Coast of Alabama. The names and themes of each of the company's restaurants are different except for its two Gallagher's Steakhouse restaurants, two Broadway Burger Bar and Grill restaurants, and two Original Oyster House restaurants. The menus in the company's restaurants provides a variety of foods.

CalAmp is a telematics solutions provider. The company's software applications, cloud services, and intelligent devices collect and assess data including industrial machines, commercial and passenger vehicles, their drivers and contents. The company operates under two reportable segments: Telematics Systems, which provide a series of telematics and stolen vehicle recovery products for the connected vehicle and emerging Internet of Machines marketplace; and Software and Subscription Services, which provide cloud-based application enablement and telematics service platforms that facilitate integration of its own applications, as well as those of third parties, through open Application Programming Interfaces.

Lazydays operates recreation vehicle (RV) dealerships and provides a portfolio of products and services for RV owners and outdoor enthusiasts. The company arranges for financing for vehicle purchases through third-party financing sources in exchange for a commission payable to it. The company provides third-party protection plans and services to the purchasers of its RVs as part of the delivery process, including extended vehicle service contracts, tire and wheel protection, guaranteed auto protection and property insurance. The company's parts and services and other include: repair and maintenance, installation of parts and accessories, collision repair, parts and accessories store, RV rentals, and RV campground.

Verrica Pharmaceuticals is a dermatology therapeutics company focused on the development and commercialization of treatments for people living with skin diseases. The company's primary product candidate, VP-102, is a proprietary drug-device combination of its topical solution of cantharidin, a naturally sourced agent to treat topical dermatological conditions, administered through its single-use precision applicator. The company is initially developing VP-102 for the treatment of molluscum contagiosum, or molluscum, a highly contagious and primarily pediatric viral skin disease, and common warts. In addition, the company is also developing VP-102 for the treatment of external genital warts.